Want to join the conversation?
$HALO 2Q15 Call: Royalty revenue grew YoverY approx. 278% to $6.4MM in 2Q15 reflecting partnered product sales in the Jan. to March 2015 period. The key driven has been has been the increasing sales of Herceptin SC. On a sequential basis, we saw decline of $400,000 in Royalty revenue due to some initial stockings of HYQVIA.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.